Cate临床试验正式启动,旨在验证使用超敏感Next Personal检测进行循环肿瘤DNA指导的乳腺癌治疗方案的临床实用性。该试验将评估这一创新检测技术在乳腺癌精准治疗中的应用价值和临床效果。
Cate临床试验正式启动,旨在验证使用超敏感Next Personal检测进行循环肿瘤DNA指导的乳腺癌治疗方案的临床实用性。该试验将评估这一创新检测技术在乳腺癌精准治疗中的应用价值和临床效果。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.